Related Experiment Video
Updated: Feb 25, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
The role of NADPH oxidases in diabetic cardiomyopathy
Synne S Hansen1, Ellen Aasum1, Anne D Hafstad1
1Cardiovascular Research Group, Department of Medical Biology, Faculty of Health Sciences, UIT-The Arctic University of Tromsø, N-9037 Tromsø, Norway.
Abstract:
Systemic changes during diabetes such as high glucose, dyslipidemia, hormonal changes and low grade inflammation, are believed to induce structural and functional changes in the cardiomyocyte associated with the development of diabetic cardiomyopathy. One of the hallmarks of the diabetic heart is increased oxidative stress. NADPH-oxidases (NOXs) are important ROS-producing enzymes in the cardiomyocyte mediating both adaptive and maladaptive changes in the heart. NOXs have been suggested as a therapeutic target for several diabetic complications, but their role in diabetic cardiomyopathy is far from elucidated. In this review we aim to provide an overview of the current knowledge regarding the understanding of how NOXs influences cardiac adaptive and maladaptive processes in a "diabetic milieu". This article is part of a Special issue entitled Cardiac adaptations to obesity, diabetes and insulin resistance, edited by Professors Jan F.C. Glatz, Jason R.B. Dyck and Christine Des Rosiers.
Insights
Diabetic cardiomyopathy involves oxidative stress from enzymes like NADPH-oxidases (NOXs). This review explores how NOXs impact heart changes in diabetes, suggesting them as potential therapeutic targets.
Area of Science:
- Cardiovascular Research
- Metabolic Diseases
- Oxidative Stress Biology
Background:
- Diabetes induces cardiomyocyte structural and functional changes, leading to diabetic cardiomyopathy.
- Increased oxidative stress, particularly via reactive oxygen species (ROS), is a key feature of the diabetic heart.
- NADPH-oxidases (NOXs) are significant ROS-producing enzymes in cardiomyocytes, influencing cardiac adaptation and maladaptation.
Purpose of the Study:
- To review current knowledge on the role of NOXs in diabetic cardiomyopathy.
- To elucidate how NOXs mediate adaptive and maladaptive cardiac processes within a diabetic environment.
- To assess the therapeutic potential of targeting NOXs in diabetic heart complications.
Main Methods:
- Literature review of existing studies on NOXs and diabetic cardiomyopathy.
- Analysis of research on ROS production by NOXs in cardiomyocytes.
- Synthesis of findings on the impact of NOXs on cardiac structure and function in diabetes.
Main Results:
- NOXs contribute significantly to oxidative stress in the diabetic heart.
- NOX enzymes play a dual role, mediating both beneficial and detrimental cardiac changes in diabetes.
- The precise mechanisms by which NOXs influence diabetic cardiomyopathy require further investigation.
Conclusions:
- NOXs are critical players in the pathophysiology of diabetic cardiomyopathy.
- Understanding NOX function in the diabetic milieu is essential for developing targeted therapies.
- Further research is warranted to fully elucidate NOX pathways for therapeutic intervention in diabetic heart disease.
Related Concept Videos
Role of Reduced Coenzymes NADH and FADH₂
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology

